nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—breast cancer—bone cancer	0.942	1	CtDrD
Fluoxymesterone—ESR1—LKB1 signaling events—ETV4—bone cancer	0.00182	0.0409	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00179	0.0403	CbGpPWpGaD
Fluoxymesterone—PRLR—Ovarian Infertility Genes—CDK4—bone cancer	0.00177	0.0398	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00176	0.0397	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.00143	0.0323	CbGpPWpGaD
Fluoxymesterone—Azoospermia—Cisplatin—bone cancer	0.00139	0.126	CcSEcCtD
Fluoxymesterone—PRLR—ErbB4 signaling events—MDM2—bone cancer	0.00122	0.0275	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptors—NR1I2—bone cancer	0.00104	0.0234	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.000988	0.0223	CbGpPWpGaD
Fluoxymesterone—Oligospermia—Methotrexate—bone cancer	0.000978	0.0887	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—bone cancer	0.000915	0.083	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—bone cancer	0.000847	0.0768	CcSEcCtD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.000845	0.0191	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.000832	0.0188	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—bone cancer	0.000819	0.0185	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000818	0.0185	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—NR1I2—bone cancer	0.000798	0.018	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—NR1I2—bone cancer	0.000786	0.0177	CbGpPWpGaD
Fluoxymesterone—Azoospermia—Methotrexate—bone cancer	0.000761	0.069	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00075	0.0169	CbGpPWpGaD
Fluoxymesterone—Azoospermia—Epirubicin—bone cancer	0.000712	0.0646	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—bone cancer	0.000659	0.0597	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00063	0.0142	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000621	0.014	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—bone cancer	0.000607	0.0137	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.00051	0.0115	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL3—bone cancer	0.000502	0.0113	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—RB1—bone cancer	0.0005	0.0113	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.000484	0.0109	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—KIT—bone cancer	0.000478	0.0108	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—JUN—bone cancer	0.000439	0.00991	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	0.000438	0.00989	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CHEK2—bone cancer	0.000424	0.00957	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.000418	0.00942	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—WT1—bone cancer	0.000415	0.00936	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—BRAF—bone cancer	0.000382	0.00862	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—MDM2—bone cancer	0.000376	0.00849	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—BRCA2—bone cancer	0.00036	0.00811	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000353	0.00796	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ZNF77—bone cancer	0.000322	0.00726	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	0.000317	0.00715	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—EZH2—bone cancer	0.000316	0.00714	CbGpPWpGaD
Fluoxymesterone—Hydrocortamate—CYP3A4—bone cancer	0.000282	0.0986	CrCbGaD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.000281	0.0255	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Cisplatin—bone cancer	0.00028	0.0254	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.000278	0.00628	CbGpPWpGaD
Fluoxymesterone—Cortisone acetate—CYP3A4—bone cancer	0.000278	0.097	CrCbGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.000275	0.00621	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.000267	0.00602	CbGpPWpGaD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.00026	0.0236	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—bone cancer	0.000257	0.0058	CbGpPWpGaD
Fluoxymesterone—Eplerenone—CYP3A4—bone cancer	0.000244	0.0852	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000236	0.00532	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.000232	0.00523	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000227	0.00512	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.000222	0.00502	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000221	0.00497	CbGpPWpGaD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—bone cancer	0.000218	0.0198	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—bone cancer	0.000218	0.0198	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000216	0.00486	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.000215	0.00485	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000215	0.00485	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000213	0.00481	CbGpPWpGaD
Fluoxymesterone—Fluorometholone—CYP3A4—bone cancer	0.000212	0.0741	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRM4—bone cancer	0.000209	0.00472	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RGS1—bone cancer	0.000209	0.00472	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000206	0.00464	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000205	0.00462	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.000203	0.00458	CbGpPWpGaD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—bone cancer	0.000202	0.0183	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—bone cancer	0.000202	0.0183	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—ZNF77—bone cancer	0.000201	0.00453	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.0002	0.00452	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000199	0.00449	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000198	0.00446	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.000188	0.00423	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000185	0.00418	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.000185	0.00417	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Methotrexate—bone cancer	0.000183	0.0166	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000183	0.00412	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000182	0.0041	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRM1—bone cancer	0.000182	0.00409	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000177	0.004	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.000177	0.00399	CbGpPWpGaD
Fluoxymesterone—Danazol—CYP3A4—bone cancer	0.000174	0.0607	CrCbGaD
Fluoxymesterone—Triamcinolone—CYP3A4—bone cancer	0.000173	0.0604	CrCbGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000172	0.00389	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000172	0.00387	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.00017	0.00384	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—bone cancer	0.00017	0.0591	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.000169	0.00382	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ATF1—bone cancer	0.000168	0.00379	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000168	0.00378	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000166	0.00375	CbGpPWpGaD
Fluoxymesterone—Alopecia—Cisplatin—bone cancer	0.000166	0.015	CcSEcCtD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.000166	0.00373	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000165	0.00372	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL3—bone cancer	0.000164	0.0037	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000164	0.0037	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000162	0.00365	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000158	0.00357	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000158	0.00356	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.000156	0.0545	CrCbGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000155	0.0035	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZNF77—bone cancer	0.000155	0.00349	CbGpPWpGaD
Fluoxymesterone—Norethindrone—CYP3A4—bone cancer	0.000155	0.054	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000154	0.00348	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000154	0.0139	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—ZNF77—bone cancer	0.000153	0.00344	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000152	0.00344	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—CYP3A4—bone cancer	0.000147	0.0513	CrCbGaD
Fluoxymesterone—Prednisolone—CYP3A4—bone cancer	0.000145	0.0505	CrCbGaD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000144	0.013	CcSEcCtD
Fluoxymesterone—Betamethasone—CYP3A4—bone cancer	0.000142	0.0495	CrCbGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.000141	0.00319	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.000141	0.00317	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000141	0.00317	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.000141	0.00317	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000139	0.00313	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—bone cancer	0.000139	0.0484	CrCbGaD
Fluoxymesterone—Anxiety—Cisplatin—bone cancer	0.000139	0.0126	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Cisplatin—bone cancer	0.000133	0.0121	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000133	0.00301	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000133	0.0121	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000132	0.00298	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000132	0.00298	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000131	0.00296	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.000131	0.00295	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.00013	0.00292	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000129	0.00291	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000128	0.00289	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMO—bone cancer	0.000128	0.00288	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000126	0.00285	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000126	0.00283	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000124	0.00281	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000123	0.00277	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.000122	0.00276	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Cisplatin—bone cancer	0.00012	0.0108	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—GNA11—bone cancer	0.000117	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—JUN—bone cancer	0.000117	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.000114	0.00258	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000114	0.00257	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—JUN—bone cancer	0.000112	0.00254	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—bone cancer	0.000111	0.00251	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.000111	0.00251	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—CYP3A4—bone cancer	0.000111	0.0386	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.00011	0.00248	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	0.000109	0.00247	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.000109	0.00246	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ATF1—bone cancer	0.000109	0.00245	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000108	0.00244	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	0.000107	0.00242	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000107	0.00241	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL3—bone cancer	0.000106	0.00239	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Methotrexate—bone cancer	0.000103	0.00938	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000103	0.00232	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Methotrexate—bone cancer	0.000103	0.00933	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000102	0.00229	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.0001	0.00226	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	9.91e-05	0.00224	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Cisplatin—bone cancer	9.82e-05	0.0089	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—FUS—bone cancer	9.82e-05	0.00221	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Epirubicin—bone cancer	9.68e-05	0.00878	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—bone cancer	9.63e-05	0.00873	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—bone cancer	9.62e-05	0.00217	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	9.58e-05	0.00216	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KIT—bone cancer	9.57e-05	0.00216	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—RB1—bone cancer	9.25e-05	0.00209	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	9.22e-05	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—bone cancer	9.19e-05	0.00207	CbGpPWpGaD
Fluoxymesterone—Alopecia—Methotrexate—bone cancer	9.1e-05	0.00825	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—TGFBR2—bone cancer	9.07e-05	0.00205	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP3A4—bone cancer	9.02e-05	0.0315	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KIT—bone cancer	8.97e-05	0.00202	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Doxorubicin—bone cancer	8.96e-05	0.00812	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—bone cancer	8.91e-05	0.00808	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—bone cancer	8.53e-05	0.00192	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP3A4—bone cancer	8.53e-05	0.0297	CrCbGaD
Fluoxymesterone—Alopecia—Epirubicin—bone cancer	8.51e-05	0.00772	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	8.48e-05	0.00191	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	8.33e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP3A4—bone cancer	8.25e-05	0.0288	CrCbGaD
Fluoxymesterone—Dexamethasone—PTGS2—bone cancer	8.08e-05	0.0282	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	8.01e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.94e-05	0.00179	CbGpPWpGaD
Fluoxymesterone—Nausea—Cisplatin—bone cancer	7.92e-05	0.00718	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—bone cancer	7.88e-05	0.00714	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—JUN—bone cancer	7.81e-05	0.00176	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.64e-05	0.00172	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—FUS—bone cancer	7.56e-05	0.00171	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MDM2—bone cancer	7.54e-05	0.0017	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—bone cancer	7.54e-05	0.0017	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—FUS—bone cancer	7.45e-05	0.00168	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—bone cancer	7.42e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	7.37e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Methotrexate—bone cancer	7.31e-05	0.00663	CcSEcCtD
Fluoxymesterone—Anxiety—Epirubicin—bone cancer	7.11e-05	0.00645	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	7.1e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MDM2—bone cancer	7.07e-05	0.00159	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—bone cancer	6.84e-05	0.0062	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—NR1I2—bone cancer	6.81e-05	0.00154	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.64e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—bone cancer	6.58e-05	0.00597	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methotrexate—bone cancer	6.57e-05	0.00595	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—JUN—bone cancer	6.55e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	6.54e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—bone cancer	6.33e-05	0.00574	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	6.3e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KIT—bone cancer	6.19e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	6.17e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Epirubicin—bone cancer	6.15e-05	0.00557	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	5.92e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.89e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—bone cancer	5.82e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—bone cancer	5.69e-05	0.00515	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.67e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—bone cancer	5.39e-05	0.00488	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	5.29e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR1I2—bone cancer	5.24e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	5.22e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR1I2—bone cancer	5.16e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—bone cancer	5.15e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.12e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—bone cancer	5.04e-05	0.00457	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—EIF2S1—bone cancer	5.03e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—bone cancer	4.87e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	4.85e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—bone cancer	4.83e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—bone cancer	4.67e-05	0.00423	CcSEcCtD
Fluoxymesterone—Headache—Methotrexate—bone cancer	4.58e-05	0.00415	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.38e-05	0.000989	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EZH2—bone cancer	4.37e-05	0.000985	CbGpPWpGaD
Fluoxymesterone—Nausea—Methotrexate—bone cancer	4.34e-05	0.00394	CcSEcCtD
Fluoxymesterone—Headache—Epirubicin—bone cancer	4.29e-05	0.00389	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—bone cancer	4.24e-05	0.000956	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—bone cancer	4.12e-05	0.00093	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	4.08e-05	0.000919	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—bone cancer	4.07e-05	0.00368	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.02e-05	0.000907	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—bone cancer	3.97e-05	0.0036	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—RGS1—bone cancer	3.93e-05	0.000887	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM4—bone cancer	3.93e-05	0.000887	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF2S1—bone cancer	3.87e-05	0.000873	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF2S1—bone cancer	3.81e-05	0.00086	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—bone cancer	3.76e-05	0.00341	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—GRM1—bone cancer	3.41e-05	0.000769	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.38e-05	0.000762	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EZH2—bone cancer	3.36e-05	0.000759	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—bone cancer	3.33e-05	0.000751	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EZH2—bone cancer	3.31e-05	0.000747	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—bone cancer	2.8e-05	0.000631	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMO—bone cancer	2.4e-05	0.000542	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNA11—bone cancer	2.2e-05	0.000495	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ATF1—bone cancer	2.04e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL3—bone cancer	1.99e-05	0.000449	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—bone cancer	1.7e-05	0.000384	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—bone cancer	1.6e-05	0.000361	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—bone cancer	1.16e-05	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—bone cancer	1.09e-05	0.000246	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—bone cancer	9.15e-06	0.000206	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—bone cancer	7.96e-06	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—bone cancer	7.74e-06	0.000175	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—bone cancer	6.25e-06	0.000141	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—bone cancer	5.25e-06	0.000118	CbGpPWpGaD
